Article 1 (aim and scope of the REACH Regulation)

Article 5 (the principle of “no data, no market”)

Article 25(1) (animal testing as a last resort)

Article 35 (access to information for workers)

Article 45 (evaluation of substances on the rolling action plan)

Article 48 (follow-up to substance evaluation)

Article 55 (the aim of Title VII, which is about authorisation of substances)

Article 67(1) (effect of restrictions contained in Annex XVII)

Article 92 or 93 (appeals)

Article 111, first subparagraph (formats and software for submission of information to the Agency)

Article 123 (communication to the public of information on risks of substances)

Article 4A (the consent requirement)

Article 129(1) (the safeguard clause: basic principles)

Article 54 (publication of information on evaluation)

Article 64(6) (publication of Agency authorisation opinions)

Article 72(2) (publication of Agency restriction opinions)

Article 77(A4) (Agency to act in a way that ensures a high degree of transparency) and (2)(e) (database(s) of registered substances)

Article 109 (general rules on transparency for the Agency)

Article 95 (conflicts of opinion with other bodies)

Article 108 (contacts with stakeholder organisations)

Article 110 (relations with relevant public bodies)

The Annexes